Talekar, Meghna <br/><br/>
Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  Jul 2015 
 - 1521-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Cell Line, Tumor<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Hyaluronic Acid--chemistry<br/>Mice, Nude<br/>Microscopy, Confocal<br/>Microscopy, Electron, Transmission<br/>Nanoparticles--chemistry<br/>Ovarian Neoplasms--genetics<br/>Paclitaxel--pharmacology<br/>Pyruvate Kinase--genetics<br/>RNA, Small Interfering--chemistry<br/>RNAi Therapeutics--methods<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tissue Distribution<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays